Harrison Rosemary
Insider CIK 1838046 · TRIL See Remarks · TCRR Chief Business & Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,822 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 76,930 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 191,102 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 76,930 | — | $0 | 76,930 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-12-15 | 2022-12-19 | 12,822 | — | $0 | 12,822 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2022-01-10 | 2022-01-12 | 191,102 | — | $0 | 191,102 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 180,000 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer | 2021-11-17 | 2021-11-19 | 75 | — | $0 | 0 | SEC↗ |